Literature DB >> 7547241

Effects of transforming growth factor beta-1 on growth-regulatory genes in tumour-derived human oral keratinocytes.

I C Paterson1, V Patel, J R Sandy, S S Prime, W A Yeudall.   

Abstract

This study examined the effect of transforming growth factor beta-1 (TGF-beta 1) on c-myc, RB1, junB and p53 expression together with pRb phosphorylation, in carcinoma-derived and normal human oral keratinocytes with a range of inhibitory responses to this ligand. Amplification of c-myc was observed in eight of eight tumour-derived cell lines and resulted in corresponding mRNA expression. The down-regulation of c-myc expression by TGF-beta 1 predominantly reflected growth inhibition by TGF-beta 1, but in two of eight tumour-derived cell lines which were partially responsive to TGF-beta 1 c-myc expression was unaltered by this ligand. While RB1 mRNA levels were unaltered by TGF-beta 1, the ligand caused the accumulation of the underphosphorylated form of the Rb protein in all cells irrespective of TGF-beta 1-induced growth arrest. junB expression was up-regulated by TGF-beta 1 in cells with a range of growth inhibitory responses. All cells contained mutant p53. TGF-beta 1 did not affect p53 mRNA expression in both tumour-derived and normal keratinocytes and there was no alteration in p53 protein levels in keratinocytes expressing stable p53 protein following TGF-beta 1 treatment. The data indicate that TGF-beta-induced growth control can exist independently of the presence of mutant p53 and the control of Rb phosphorylation and c-myc down-regulation. It may be that TGF-beta growth inhibition occurs via multiple mechanisms and that the loss of one pathway during tumour progression does not necessarily result in the abrogation of TGF-beta-induced growth control.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7547241      PMCID: PMC2034046          DOI: 10.1038/bjc.1995.434

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

1.  Modifications of cell cycle controlling nuclear proteins by transforming growth factor beta in the HaCaT keratinocyte cell line.

Authors:  Y Landesman; M Pagano; G Draetta; V Rotter; N E Fusenig; A Kimchi
Journal:  Oncogene       Date:  1992-08       Impact factor: 9.867

2.  Release from G1 growth arrest by transforming growth factor beta 1 requires cellular ras activity.

Authors:  P H Howe; S F Dobrowolski; K B Reddy; D W Stacey
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

3.  Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1.

Authors:  B I Gerwin; E Spillare; K Forrester; T A Lehman; J Kispert; J A Welsh; A M Pfeifer; J F Lechner; S J Baker; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

4.  Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes.

Authors:  K Münger; J A Pietenpol; M R Pittelkow; J T Holt; H L Moses
Journal:  Cell Growth Differ       Date:  1992-05

5.  Consistent chromosomal anomalies in keratinocyte cell lines derived from untreated malignant lesions of the oral cavity.

Authors:  V Patel; W A Yeudall; A Gardner; S Mutlu; C Scully; S S Prime
Journal:  Genes Chromosomes Cancer       Date:  1993-06       Impact factor: 5.006

6.  TGF beta signals through a heteromeric protein kinase receptor complex.

Authors:  J L Wrana; L Attisano; J Cárcamo; A Zentella; J Doody; M Laiho; X F Wang; J Massagué
Journal:  Cell       Date:  1992-12-11       Impact factor: 41.582

7.  Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes.

Authors:  S M Game; A Huelsen; V Patel; M Donnelly; W A Yeudall; A Stone; N E Fusenig; S S Prime
Journal:  Int J Cancer       Date:  1992-09-30       Impact factor: 7.396

8.  Escape from transforming growth factor beta control and oncogene cooperation in skin tumor development.

Authors:  C Missero; S Ramon y Cajal; G P Dotto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

9.  Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities.

Authors:  R H Chen; R Ebner; R Derynck
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

Review 10.  Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis.

Authors:  T M Fynan; M Reiss
Journal:  Crit Rev Oncog       Date:  1993
View more
  6 in total

1.  Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model.

Authors:  Taisuke Ito; Natsuho Ito; Albrecht Bettermann; Yoshiki Tokura; Masahiro Takigawa; Ralf Paus
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

2.  p400 function is required for the adenovirus E1A-mediated suppression of EGFR and tumour cell killing.

Authors:  M B Flinterman; J S Mymryk; P Klanrit; A F Yousef; S W Lowe; C Caldas; J Gäken; F Farzaneh; M Tavassoli
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

3.  Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity.

Authors:  R C Jordan; G Bradley; J Slingerland
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

4.  Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma.

Authors:  Lihua Hu; Jingpeng Liu; Zhi Li; Chunling Wang; Ali Nawshad
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2016-06-08

5.  Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells.

Authors:  G J Thomas; I R Hart; P M Speight; J F Marshall
Journal:  Br J Cancer       Date:  2002-10-07       Impact factor: 7.640

6.  Susceptibility of Human Oral Squamous Cell Carcinoma (OSCC) H103 and H376 cell lines to Retroviral OSKM mediated reprogramming.

Authors:  Nalini Devi Verusingam; Swee Keong Yeap; Huynh Ky; Ian C Paterson; Suan Phaik Khoo; Soon Keng Cheong; Alan H K Ong; Tunku Kamarul
Journal:  PeerJ       Date:  2017-04-13       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.